“Adjusted premiums, fees and other revenues, net of foreign currency fluctuations, increased $89 million, or 12%, compared to the prior period primarily due to strong sales and solid renewal activity across the region.”10-Q · Aug 6, 2026 ↗
MetLife, Inc.
MET
Market read
MetLife, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
- MET's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if MET's group or a disclosed connection begins moving with it.
Research brief
The story so far
No new filing conclusion is available. 0 of 7 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 5 directly disclosed connections are confirming.
No thresholded supportive filing evidence is available yet.
No thresholded adverse filing evidence is available yet.
- MET's market-adjusted activity becomes unusual and at least one connected name confirms.
Company research
Understand the business, not just the ticker
Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.
- Which operating variable is changing?
- Is that change durable, cyclical or one-off?
- What evidence would disprove the current interpretation?
- Latest annual revenue changed +8.5% year over year.
- Operating cash flow covered net income at 5.06x in the latest annual period.
- Foreign exchange has repeated favorable evidence across 5 filings.
- Operating margin changed -15.2 percentage points in the latest annual period.
- Net margin changed -58.4 percentage points in the latest annual period.
- P/E is 59% above the available filing-peer median; determine whether growth and quality justify the difference.
- EV/sales is 1053% above the available filing-peer median; determine whether growth and quality justify the difference.
Price as of Sep 10, 2026
96.78Reported annual revenue and per-share history. This is accounting history, not a forecast.
What management says matters
Persistent and emerging business drivers
“As a result of our impairment analysis, we recorded an impairment l oss of $193 million and $1 million for the six months ended June 30, 2026 and 2025, respectively.”10-Q · Aug 6, 2026 ↗
“Excluding these notable items from the denominator of the ratio, the adjusted free cash flow ratio for 2025 would be 82%.”10-K · Feb 19, 2026 ↗
“Our retained asset accounts experience gross margin compression due to minimum crediting rate guarantees.”10-K · Feb 19, 2026 ↗
Valuation discipline
Descriptive valuation snapshot
Price/sales 26.7× · EV/sales 17.7×. Comparisons use only industry-matched filing peers.
Scenarios are withheld for Financial Services until sector-specific earnings and capital metrics are available; generic revenue/P/S scaffolds would be misleading.
Price action
How the market is pricing the story
Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 10:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.
Developments
No sourced recent-development timeline yet
Jodie has not returned a relevant primary source or news item for MET. This is an evidence-coverage gap, not a conclusion that nothing material happened.
Business and financial condition
Reported financial figures are not available yet
Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.
Filing analysis
No comparable filing assessment is available yet
Jodie has not yet found a suitable current-versus-prior filing comparison for MET. This does not mean the latest filing was neutral or immaterial.
Business ecosystem
The relationships behind MET
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depended on by
CNOCNO Financial Group, Inc.competitorFeb 24, 2026 ▾
“Our main competitors for supplemental health products sold through our Worksite Division include AFLAC, subsidiaries of Unum, MetLife, Chubb/Combined, and Voya.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 4 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MET is currently a Early Follower in the organic co-movement group Insurance - Life. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 1 filing-linked name are in the relationship map; none is currently confirmed as moving with the group.
Context history
Theme membership history
No durable theme membership has been observed for this name yet.